Ward Shane, COO and CLO of Cidara Therapeutics ($CDTX), sold shares once on the open market in the last year, totaling $2.2 million. His most recent sale occurred on December 10, 2025. These sales rank 3,319th among 11,678 individual insiders, below the average of $8.6 million per seller and 6 transactions. Shane made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | D | Common Stock | 25083 | $221.50 | 0.0000 | 31,439,371 | 100.00% | 0.08% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | D | Employee Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.16% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | D | Employee Stock Option (right to buy) | 135540 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.43% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | D | Employee Stock Option (right to buy) | 12499 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.04% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | D | Employee Stock Option (right to buy) | 6207 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.02% |
| Jan. 7, 2026 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | D | Employee Stock Option (right to buy) | 12500 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.04% |
| Dec. 10, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | M | Common Stock | 6459 | $20.20 | 34,592.0000 | 31,439,371 | 22.96% | 0.02% |
| Dec. 10, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | F | Common Stock | 15041 | $219.60 | 24,633.0000 | 31,439,371 | 37.91% | 0.05% |
| Dec. 10, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | M | Common Stock | 3500 | $16.65 | 28,133.0000 | 31,439,371 | 14.21% | 0.01% |
| Dec. 10, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | S | Common Stock | 9959 | $220.08 | 25,033.0000 | 31,439,371 | 28.46% | 0.03% |
| Dec. 10, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | M | Employee Stock Option (right to buy) | 3500 | $0.00 | 0.0000 | 31,439,371 | 100.00% | 0.01% |
| Dec. 10, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | M | Employee Stock Option (right to buy) | 6459 | $0.00 | 6,207.0000 | 31,439,371 | 50.99% | 0.02% |
| March 31, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | A | Common Stock | 25000 | $0.00 | 39,674.0000 | 10,953,490 | 170.37% | 0.23% |
| March 31, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 10,953,490 | 9999.99% | 0.46% |
| March 11, 2025 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | S | Common Stock | 1664 | $21.96 | 14,674.0000 | 10,953,490 | 10.18% | 0.02% |
| Sept. 30, 2024 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | A | Employee Stock Option (right to buy) | 135540 | $0.00 | 135,540.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | A | Common Stock | 120000 | $0.00 | 318,770.0000 | 0 | 60.37% | 0.00% |
| March 15, 2024 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2024 | Cidara Therapeutics, Inc. | $CDTX | Ward Shane | COO & CLO | S | Common Stock | 20473 | $0.67 | 198,770.0000 | 0 | 9.34% | 0.00% |